Graft Versus Host Disease (GvHD) Market to Make Great Impact in Near Future: Players Sanofi, Novartis AG, Neovii Biotech GmbH, Merck & Co.
Stem cell and bone marrow transplants may often lead to mild or severe some complications. These complications can be referred as graft versus host disease (Gvhd) and occur especially in immune-compromised patients. The radioactive agents or chemicals used during cancer treatment can have adverse impact on healthy cells, which may lead to reconstruction of the body cells. Stem cell and bone marrow transplant can be used to fix this reconstruction. A patient receives the bone marrow from a donor through...
View full press release